Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys503
Sells8732
Buy $$20.36B
Sell $$14.25B
Ratio1.43:1
% Change vs. Prior
Ratio +1981.3%Value +308.5%
Healthcare
Buys628
Sells4566
Buy $$625.03M
Sell $$16.67B
Ratio1:26.68
% Change vs. Prior
Ratio -82.9%Value +57.1%
Industrials
Buys448
Sells2098
Buy $$331.41M
Sell $$7.52B
Ratio1:22.69
% Change vs. Prior
Ratio +218.2%Value -1.3%
Energy
Buys300
Sells785
Buy $$143.77M
Sell $$5.23B
Ratio1:36.41
% Change vs. Prior
Ratio -12.8%Value +156.1%
Financial Services
Buys1505
Sells2533
Buy $$653.07M
Sell $$3.79B
Ratio1:5.81
% Change vs. Prior
Ratio -29.5%Value -31.1%
Consumer Cyclical
Buys375
Sells2024
Buy $$1.38B
Sell $$2.93B
Ratio1:2.13
% Change vs. Prior
Ratio +183.5%Value +25.1%
Consumer Defensive
Buys150
Sells765
Buy $$136.59M
Sell $$1.85B
Ratio1:13.58
% Change vs. Prior
Ratio +116.3%Value -60.2%
Communication Services
Buys169
Sells776
Buy $$147.83M
Sell $$1.39B
Ratio1:9.40
% Change vs. Prior
Ratio +96.0%Value +64.7%
Utilities
Buys69
Sells283
Buy $$70.45M
Sell $$1.41B
Ratio1:20.04
% Change vs. Prior
Ratio +36515.2%Value -78.2%
Basic Materials
Buys166
Sells293
Buy $$106.53M
Sell $$626.58M
Ratio1:5.88
% Change vs. Prior
Ratio -25.0%Value -16.2%
Real Estate
Buys190
Sells364
Buy $$97.11M
Sell $$235.71M
Ratio1:2.43
% Change vs. Prior
Ratio +90.3%Value -12.4%
By Industry
Hardware, Equipment & Parts
Buys31
Sells749
Buy $$19.90B
Sell $$645.59M
Ratio30.83:1
Medical - Instruments & Supplies
Buys48
Sells105
Buy $$30.09M
Sell $$11.25B
Ratio1:373.85
% Change vs. Prior
Ratio -98.7%Value +259.7%
Software - Infrastructure
Buys58
Sells2986
Buy $$49.16M
Sell $$5.02B
Ratio1:102.12
% Change vs. Prior
Ratio -53.8%Value +217.2%
Oil & Gas Exploration & Production
Buys174
Sells186
Buy $$51.67M
Sell $$3.21B
Ratio1:62.06
Semiconductors
Buys83
Sells1662
Buy $$3.38M
Sell $$2.77B
Ratio1:820.69
% Change vs. Prior
Ratio -67.6%Value +6.4%
Engineering & Construction
Buys13
Sells219
Buy $$2.12M
Sell $$2.31B
Ratio1:1085.34
% Change vs. Prior
Ratio -57.6%Value +114.4%
Biotechnology
Buys341
Sells3157
Buy $$368.62M
Sell $$1.87B
Ratio1:5.07
% Change vs. Prior
Ratio -67.4%Value -37.1%
Software - Application
Buys245
Sells1565
Buy $$375.39M
Sell $$1.75B
Ratio1:4.67
% Change vs. Prior
Ratio -16.2%Value -0.3%
Specialty Retail
Buys84
Sells1007
Buy $$159.46M
Sell $$1.84B
Ratio1:11.56
% Change vs. Prior
Ratio +49.0%Value +84.0%
Rental & Leasing Services
Buys9
Sells128
Buy $$1.29M
Sell $$1.87B
Ratio1:1451.24
Medical - Diagnostics & Research
Buys19
Sells352
Buy $$10.86M
Sell $$1.70B
Ratio1:156.95
Computer Hardware
Buys5
Sells857
Buy $$455.54K
Sell $$1.65B
Ratio1:3616.61
Shell Companies
Buys112
Sells320
Buy $$114.82M
Sell $$1.47B
Ratio1:12.81
Information Technology Services
Buys59
Sells203
Buy $$7.69M
Sell $$1.50B
Ratio1:194.64
Renewable Utilities
Buys21
Sells154
Buy $$57.47M
Sell $$1.16B
Ratio1:20.27
% Change vs. Prior
Ratio +146995.7%Value -11.7%
Transactions (23294)
Cloudflare, Inc. (NET)
Prince Matthew — Director
Shares
1,454
Price
$208.14
Total Value
$302.64K
Shares Held After
50,930
% of Holdings
2.8%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
405
Price
$56.26
Total Value
$22.79K
Shares Held After
28,975
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
1,487
Price
$55.39
Total Value
$82.36K
Shares Held After
29,380
% of Holdings
4.8%
BARRETT BUSINESS SERVICES INC (BBSI)
Potts James R — EVP Gen Counsel & Secretary
Shares
1,803
Price
$28.68
Total Value
$51.71K
Shares Held After
33,837
% of Holdings
5.1%
Snowflake Inc. (SNOW)
Slootman Frank — Director
Shares
7,874
Price
$175.34
Total Value
$1.38M
Shares Held After
38,046
% of Holdings
17.1%
Snowflake Inc. (SNOW)
Dageville Benoit — Director
Shares
1,919
Price
$175.34
Total Value
$336.48K
Shares Held After
53,262
% of Holdings
3.5%
UNIVERSAL TECHNICAL INSTITUTE INC (UTI)
Brochick George W. — Director
Shares
5,000
Price
$36.59
Total Value
$182.94K
Shares Held After
27,516
% of Holdings
15.4%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
10,043
Price
$28.10
Total Value
$282.21K
Shares Held After
62,085
% of Holdings
13.9%
BLACKSTONE MORTGAGE TRUST, INC. (BXMT)
URBASZEK MARCIN — Chief Financial Officer
Shares
452
Price
$19.13
Total Value
$8.65K
Shares Held After
26,176
% of Holdings
1.7%
Travel & Leisure Co. (TNL)
HERRERA GEORGE — Director
Shares
1,214
Price
$70.48
Total Value
$85.56K
Shares Held After
3,601
% of Holdings
25.2%
WEX Inc. (WEX)
Kimball Jennifer — Chief Accounting Officer
Shares
715
Price
$157.82
Total Value
$112.84K
Shares Held After
6,203
% of Holdings
10.3%
GAP INC (GAP)
Gruber Julie — Chief Legal&Compliance Officer
Shares
74,217
Price
$23.85
Total Value
$1.77M
Shares Held After
53,970
% of Holdings
57.9%
GAP INC (GAP)
Breitbard Mark — President & CEO, Gap Brand
Shares
119,155
Price
$23.80
Total Value
$2.84M
Shares Held After
135,884
% of Holdings
46.7%
GAP INC (GAP)
O'Connell Katrina — Chief Financial Officer
Shares
119,155
Price
$23.80
Total Value
$2.84M
Shares Held After
11,503
% of Holdings
91.2%
GAP INC (GAP)
O'Connell Katrina — Chief Financial Officer
Shares
34,258
Price
$24.00
Total Value
$822.19K
Shares Held After
130,658
% of Holdings
20.8%
AXON ENTERPRISE, INC. (AXON)
Nardini Erika — Director
Shares
198
Price
$506.58
Total Value
$100.30K
Shares Held After
1,946
% of Holdings
9.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.40
Total Value
$255.40K
Shares Held After
499,258
% of Holdings
3.7%
ALPHA PRO TECH LTD (APT)
RITOTA JOHN — Director
Shares
2,260
Price
$4.94
Total Value
$11.16K
Shares Held After
41,355
% of Holdings
5.2%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
22,290
Price
$50.73
Total Value
$1.13M
Shares Held After
17,044
% of Holdings
56.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
27,710
Price
$49.95
Total Value
$1.38M
Shares Held After
39,334
% of Holdings
41.3%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
10,172
Price
$73.21
Total Value
$744.66K
Shares Held After
82,660
% of Holdings
11.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
23,928
Price
$62.15
Total Value
$1.49M
Shares Held After
430,330
% of Holdings
5.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
12,673
Price
$62.15
Total Value
$787.63K
Shares Held After
454,258
% of Holdings
2.7%
HERSHEY CO (HSY)
Shares
114
Price
$220.73
Total Value
$25.16K
Shares Held After
2,046,119
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
10
Price
$219.40
Total Value
$2.19K
Shares Held After
2,046,233
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
51
Price
$218.65
Total Value
$11.15K
Shares Held After
2,046,243
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
7,068
Price
$217.51
Total Value
$1.54M
Shares Held After
2,046,294
% of Holdings
0.3%
HERSHEY CO (HSY)
Shares
2,214
Price
$216.74
Total Value
$479.86K
Shares Held After
2,053,362
% of Holdings
0.1%
HERSHEY CO (HSY)
Shares
543
Price
$215.57
Total Value
$117.06K
Shares Held After
2,055,576
% of Holdings
0.0%
indie Semiconductor, Inc. (INDI)
Aoki Ichiro — Director
Shares
50,000
Price
$2.59
Total Value
$129.44K
Shares Held After
100,952
% of Holdings
33.1%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
4,397
Price
$62.15
Total Value
$273.27K
Shares Held After
153,902
% of Holdings
2.8%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
7,636
Price
$62.15
Total Value
$474.58K
Shares Held After
158,299
% of Holdings
4.6%
GLOBAL PARTNERS LP (GLP)
Romaine Mark — Chief Operating Officer
Shares
7,500
Price
$47.39
Total Value
$355.43K
Shares Held After
151,609
% of Holdings
4.7%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,916
Price
$62.15
Total Value
$181.23K
Shares Held After
71,573
% of Holdings
3.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
1,100
Price
$81.40
Total Value
$89.54K
Shares Held After
140,750
% of Holdings
0.8%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
1,546
Price
$80.28
Total Value
$124.11K
Shares Held After
141,850
% of Holdings
1.1%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
460
Price
$78.80
Total Value
$36.25K
Shares Held After
143,396
% of Holdings
0.3%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
4,167
Price
$78.07
Total Value
$325.32K
Shares Held After
143,856
% of Holdings
2.8%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
2,637
Price
$77.10
Total Value
$203.33K
Shares Held After
148,023
% of Holdings
1.8%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%
Lazard, Inc. (LAZ)
Orszag Peter Richard — Director
Shares
2,000
Price
$41.66
Total Value
$83.32K
Shares Held After
210,942
% of Holdings
0.9%
Lazard, Inc. (LAZ)
Orszag Peter Richard — Director
Shares
67,170
Price
$40.73
Total Value
$2.74M
Shares Held After
212,942
% of Holdings
24.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$538.41
Total Value
$587.40K
Shares Held After
43,082
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.32
Total Value
$537.32K
Shares Held After
44,173
% of Holdings
2.2%
Showing 5651–5700 of 23294 transactions (page 114 of 466)